The US Food and Drug Administration (FDA) has approved a new medication to treat Parkinson's disease (PD).

Traumatic brain injuries (TBIs) with loss of consciousness may have a long-term impact on neurological health, a new study found.

The US Food and Administration (FDA) has approved the first ultrasound device to treat essential tremors.

The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.

Physicians commonly prescribe antipsychotic drugs to treat psychosis associated with Parkinson's. However, a new study published in JAMA Neurology suggests that these drugs may be causing additional harm.

Parkinson’s disease has long been in the public eye, partly due to efforts by affected celebrities like Michael J. Fox. But a cure remains elusive. However, an unexpected treatment may improve some of the disease’s most debilitating symptoms.

Patients with Parkinson's disease (PD) may be able to continue taking their medications without risking cognitive decline, new evidence suggests. {C}

Pop a pill to boost your brainpower — it’s been a theory for a while but may now be closer to reality.

Sometimes important scientific discoveries occur secondhand. For Parkinson's disease, that may be exactly the case.

Depression is a complex illness with many possible causes and many treatments. And it may increase the risk of another serious health condition.